Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Garcia-Garcia, HM; Waksman, R; Melaku, GD; Garg, M; Beyene, S; Wlodarczak, A; Kerai, A; Levine, MB; van, der, Schaaf, RJ; Torzewski, J; Ferdinande, B; Escaned, J; Iglesias, JF; Bennett, J; Toth, GG; Joner, M; Toelg, R; Wiemer, M; Olivecrona, G; Vermeersch, P; Haude, M.
Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold.
Eur Heart J Cardiovasc Imaging. 2024; 25(4):491-497 Doi: 10.1093/ehjci/jead299
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Toth-Gayor Gabor
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
AIMS: The aim of the study is to assess the impact of the baseline plaque composition on the DREAMS 3G luminal late loss and to compare the serial plaque changes between baseline and 6 and 12 months (M) follow-up. METHODS AND RESULTS: A total of 116 patients were enrolled in the BIOMAG-I trial. Patients were imaged with optical coherence tomography (OCT) pre- and post-DREAMS 3G implantation and at 6 and 12 M. OCTPlus software uses artificial intelligence to assess composition (i.e. lipid, calcium, and fibrous tissue) of the plaque. The differences between the OCT-derived minimum lumen area (MLA) post-percutaneous coronary intervention and 12 M were grouped into three terciles. Patients with larger MLA differences at 12 M (P = 0.0003) had significantly larger content of fibrous tissue at baseline. There was a reduction of 24.8% and 20.9% in lipid area, both P < 0.001, between the pre-DREAMS 3G OCT and the 6 and 12 M follow-up. Conversely, the fibrous tissue increased by 48.4% and 36.0% at 6 and 12 M follow-up, both P < 0.001. CONCLUSION: The larger the fibrous tissue in the lesion at baseline, the larger the luminal loss seen at 6 and 12 M. Following the implantation of DREAMS 3G, favourable healing of the vessel coronary wall occurs as shown by a decrease in the lipid area and an increase in fibrous tissue.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Absorbable Implants - administration & dosage
Artificial Intelligence - administration & dosage
Coronary Angiography - administration & dosage
Coronary Artery Disease - administration & dosage
Coronary Vessels - administration & dosage
Drug-Eluting Stents - administration & dosage
Lipids - administration & dosage
Percutaneous Coronary Intervention - administration & dosage
Plaque, Atherosclerotic - administration & dosage
Tomography, Optical Coherence - methods
Treatment Outcome - administration & dosage

Find related publications in this database (Keywords)
optical coherence tomography
minimum lumen area
percutaneous coronary intervention
drug-eluting stent
bioresorbable stent
de novo coronary lesion
© Med Uni GrazImprint